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Abstract
Background: Peperomia pellucida is popularly known as coraçãozinho in the Brazilian northeast and
is used in the treatment of abscesses, furuncles, and conjunctivitis. Our work aimed to determine
the term of the development stages and the species cycle in the four seasons of the year (complete
development, beginning of bloom, complete bloom, and seed set), verifying the plant's therapeutic
profile during the four distinct development phases in order to detect differences in its potency.
Pharmacological tests were performed to observe the anti-inflammatory activity.
Results: Phenological observations were accessed for a 12 month-period, from the Brazilian
summer of 1999/2000 to fall 2000. On average the plantules' emergence occurred 15 days after
seeding. All plantules grew in a similar manner up to 25 days after transplantation in all seasons.
Starting on the 25th day, we observed faster growth during spring, with plants reaching a height of
about 60 cm after 100 days of transplantation, unlike other seasons, in which plants reached heights
of 40, 40, and 35 cm during winter, summer, and fall, respectively. The P. pellucida aqueous extract
showed significant anti-inflammatory activity during phenophases 1 and 2 of winter and spring.
Depending on the plant's phenophase there was variation in the potency of edema inhibition.
Conclusion: P. pellucida has a phenological cycle of approximately 100 days. It is recommended
that the P. pellucida aqueous extract is used as an antiedematogenic only during phenophases 1 and
2 of winter and spring.
Background
Peperomia pellucida (L.) HBK (Piperaceae) is popularly
known in Brazilian northeast as coraçãozinho, língua de sa-
po, herva-de-vidro or herva-de-jaboti. It is a herbaceous plant
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and axillary efflorescences, at the opposite side from
leaves, developing well in loose and humid soil by the tree
shadows.[1]
In folk medicine, this species is employed on abscesses,
furuncles, and skin sores, as well as eye inflammation
(conjunctivitis). Literature data confirm the species anti-
microbial [2] and analgesic[3] effects while other activi-
ties, such as anti-inflammatory, were not yet studied.
Other therapeutic properties are also attributed to P. pellu-
cida depending on the region. There are popular descrip-
tions of P. pellucida to lower cholesterol levels (northeast),
or used on proteinuria and as diuretic (Guyana).[4] Other
species of Peperomia were found to have wound healing
properties.[5] Phytochemical studies revealed the pres-
ence of dill-apiol and pellucidin A, in Peperomia pelluc-
ida.[6] There are several reports about purification of
compounds from the Peperomia genus. [7–10] In order to
develop cultivation techniques, medicinal plant's phenol-
ogy is one of the first data to be obtained. The name phe-
nology is defined as the study of the plants and animals
seasonal rhythm, including their life cycle events or phar-
macological activities during each season of the year.
These rhythms are closely related to climate changes.[11]
The superior plant's phenological events are the emer-
gence, growth, induction, seed establishing and dormancy
breakage, leaves production and fall, induction and devel-
opment of floral gems, anthesis, fruits production and
maturation, and seeds dispersion, as well as other phe-
nomena.[12]
The right season to collect the herbs should be determined
aiming, not only the amount of plant to be collected, but
also a minimal amount of active principles, which is of ex-
treme importance for the production of phytotherapeu-
tics.
The only report of phenology involving medicinal plants
was briefly described by Panizza.[13] The Kalanchoe brasil-
iensis is popularly used as an anti-inflammatory and vali-
dated by pharmacological studies.[13,14] However
Santos et al,[15] studying the same species, verified that
right after floration the plant did not possess any anti-in-
flammatory property, on the contrary, it stimulates the in-
flammation process. The active principle levels may vary
as a function of the plant's developing stage and/or the
edapho-climatic conditions where it grows. In view of
these facts there is an urge for studying the phenological
phenomena of species, with the goal to determine the lev-
el of active principles on all plant's stages, and in this way
determine which season the plant presents the highest lev-
el of active principles. In order to perform this study, it is
necessary to collect the plant's material during all devel-
opment stages, submitting this material for pharmacolog-
ical tests. Although phenology is a valuable scientific and
economical knowledge, researches on this field are still
scarce. However it is possible to find some reports, such as
the Lychnophora pinaster Mart.,[16]Egletes viscosa,[17] and
Mentha arvensis L. var. piperacens Moor.[18]
In this work we wish to present a new approach to deter-
mine the pharmacological aspects of phenology. In other
words, our goal was to determine the phenological stages
span on all four seasons of the year, as well as, to verify the
pharmacological activity during those development phas-
es (complete development, beginning of bloom, com-
plete bloom and seed set) through pharmacological tests.
Using this methodology it is possible to confirm whether
a plant's therapeutic value is modified or not during its de-
velopment.
Results
Germination and phenology
The beginning of seed germination under our laboratory
conditions occurred four days after seeding, where 78%
germinated after 24 days (Figure 1).
Phenological observations were evaluated for a 12-month
period, from summer 1999/2000 to spring 2000. Plan-
tules emergence occurred 15 days after seeding, on aver-
age. The growth was similar for all plants up to 24 days
after transplantation (DAT), in all seasons. Starting from
the previous date, we observed faster increase during
spring, when all plants were about 60 cm high after 100
DAT, against 40, 40, and 35 cm during winter, summer,
and fall, respectively (Figure 2).
Figure 1
Peperomia pellucida seed germination in distilled
water at room temperature. Starting from the 4th day,
when seeds initiated to germinate, until the 24th day where
the germination rate reached 78%.
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the native one. Usually, native P. pellucida grows and de-
velops during rainy periods (winter in Brazil's northeast).
Growing under the shadows and in places rich in organic
matter.
The number of leaves per plant was directly proportional
to plant growth, obtaining an average of 130, 69, 62, and
32 leaves per plant during spring, summer, fall, and win-
ter, respectively (Figure 3).
P. pellucida showed to have a relative short cycle, emerging
two terminal and axillary efflorescences at the opposite
side from leaves after 44 DAT during summer, 33 DAT
during fall, 37 DAT during winter, and 27 DAT during
spring (Figure 4).
Antiedematogenic activity
The P. pellucida aqueous extract showed antiedematogenic
activity in all seasons of the year, which this study was per-
formed, although the potency of edema inhibition was
different, depending on the plant's phenophase (Tables 1
to 4). Plants collected during summer showed moderate
edema inhibition during all phenophases, with values of
33, 34.5, 43.5, and 32% at the vegetative (phenophase 1),
beginning of bloom (phenophase 2), complete bloom
(phenophase 3), and seed set (phenophase 4), respective-
ly. There were no significant differences between all four
phases of development during summer (Table 1).
During fall, phenophases 2 (inhibition = 36.7%) and 4
(inhibition = 34.4%) showed the highest values of edema
inhibition, however without substantial differences be-
tween both phenophases (Table 2). Phenophases 1 and 3
did not show statistically significant inhibition values.
Although P. pellucida plants grow on a slower rhythm dur-
ing winter, the aqueous extract inhibited the rat paw ede-
ma mainly on phenophases 1, 2, and 4 with values of
41.6%, 36.7%, and 36.9% respectivelly. Phenophase 3 in-
hibited edema only by 21.1% (Table 3). The anti-inflam-
matory activity of plants cultivated during spring, also
showed to be effective during phenophases 1 and 2, with
inhibition values of 43% (phenophase 1), 42% (phen-
ophase 2), 24.5% (phenophase 3), and 27.4% (phen-
ophase 4, Table 4). Individual percentage values are
shown below each paw volume in all tables. Total inhibi-
tion percentage is shown at the end of tables.
Discussion
Cultivation and phenology
By analyzing Figures 2 and 3 it is possible to notice that
plants cultivated during winter, although growing to the
same height as summer plants, presented half the number
of leaves per plant. We suppose reduction in the number
of leaves occurs because the plants are estiolated during
this period, which is probably caused by higher cloudi-
ness and less time of photoperiod.
During spring season, P. pellucida plants started the efflo-
rescence earlier than other seasons. Generally about seven
days after efflorescence the first fruits appear, which are
small and drupe.[19] The fruits need seven more days to
turn mature (brown) and able to disperse.
Winter was the least proficient period to cultivate this spe-
cies, probably because of the rain excess and lack of lumi-
nosity in a screen protected environment. During this
period, plants presented on average 13 flower stalks/plant
after 100 DAT, while during spring this number increases
to 89, during summer 37, and during fall 23 flower stalks/
Figure 2
Peperomia pellucida height on four seasons of the
year. The plants grow more during spring.
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Figure 3
Number of leaves per plant on all four seasons of the
year. Similar to their growth, the plants have more leaves
during spring.
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Number of flower stalks per plant during all four seasons of the year. The graphic shows the total number of flower
stalks, as well as, flower stalks with and without seeds for a 120 days period.
Table 1: Effect of Peperomia pellucida aqueous extract (AE) p.o. on rat paw edema induced by carrageenan on different plant phases, 
during summer.
Treatment Rat paw volumes after 1, 2, 3, and 4 h after Carrageenan injection (mL) mean ± SEM (individual % inhibition) Edema % inhibition
1 h 2 h 3 h 4 h
Control 0.463 ± 0.037 0.731 ± 0.085 0.819 ± 0.062 0.642 ± 0.049 -
Indomethacin 10 0.080 ± 0.011** (82.7) 0.144 ± 0.018** (80.3) 0.232 ± 0.052** (71.7) 0.150 ± 0.059** (76.6) 77.2
Phenophase 1 0.297 ± 0.037 (35.9) 0.486 ± 0.097* (33.5) 0.516 ± 0.094* (37.0) 0.484 ± 0.082* (24.6) 33.0
Phenophase 2 0.372 ± 0.067 (19.7) 0.451 ± 0.039* (38.3) 0.514 ± 0.041* (37.2) 0.402 ± 0.038* (37.4) 34.5
Phenophase 3 0.249 ± 0.054 (46.2) 0.381 ± 0.051* (47.9) 0.471 ± 0.030* (42.5) 0.402 ± 0.035* (37.4) 43.5
Phenophase 4 0.370 ± 0.037 (20.1) 0.464 ± 0.030* (36.5) 0.561 ± 0.038* (31.5) 0.410 ± 0.032* (36.1) 32.0
Statistical significance: *p < 0.05, **p < 0.01 Vs control
0 20 40 60 80 100 120
Time (days)
0
20
40
60
80
100
N
u
m
be
r
o
ff
lo
w
e
r
st
a
lk
s/
pl
a
n
t Total
With mature seeds
Without seeds
Summer
0 20 40 60 80 100 120
Time (days)
0
20
40
60
80
100
Nu
m
be
r
o
ff
lo
w
e
r
st
a
lk
s/
pl
a
n
t Total
With mature seeds
Without seeds
Fall
0 20 40 60 80 100 120
Time (days)
0
20
40
60
80
100
Nu
m
be
r
o
ff
lo
w
e
r
st
a
lk
s/
pl
a
n
t Total
With mature seeds
Without seeds
Winter
0 20 40 60 80 100 120
Time (days)
0
20
40
60
80
100
Nu
m
be
r
o
ff
lo
w
e
r
st
a
lk
s/
pl
a
n
t Total
With mature seeds
Without seeds
SpringPage 4 of 8
(page number not for citation purposes)
BMC Pharmacology 2002, 2 http://www.biomedcentral.com/1471-2210/2/12Table 2: Effect of Peperomia pellucida aqueous extract (EA) p.o. on rat paw edema induced by carragenaan on different plant phases, 
during fall.
Treatment Rat paw volumes after 1, 2, 3, and 4 h after Carrageenan injection (mL) mean ± SEM (individual % inhibition) Edema % inhibition
1 h 2 h 3 h 4 h
Control 0.463 ± 0.037 0.731 ± 0.085 0.819 ± 0.062 0.642 ± 0.049 -
Indomethacin 10 0.080 ± 0.011** (82.7) 0.144 ± 0.018** (80.3) 0.232 ± 0.052** (71.7) 0.150 ± 0.059** (76.6) 77.2
Phenophase 1 0.431 ± 0.086 (6.9) 0.621 ± 0.061 (15.0) 0.794 ± 0.067 (3.1) 0.530 ± 0.063 (17.4) 10.5
Phenophase 2 0.351 ± 0.037 (24.2) 0.457 ± 0.024 (37.5) 0.502 ± 0.017** (38.7) 0.369 ± 0.021* (42.5) 36.7
Phenophase 3 0.306 ± 0.051* (33.9) 0.544 ± 0.064 (25.6) 0.639 ± 0.042* (22.0) 0.495 ± 0.043 (22.9) 25.3
Phenophase 4 0.226 ± 0.044** (51.2) 0.457 ± 0.038* (37.5) 0.545 ± 0.044** (33.5) 0.492 ± 0.039 (23.4) 34.4
Statistical significance: *p < 0.05, **p < 0.01 Vs control
Table 3: Effect of Peperomia pellucida aqueous extract (EA) p.o. on rat paw edema induced by carragenaan on different plant phases, 
during winter.
Treatment Rat paw volumes after 1, 2, 3, and 4 h after Carrageenan injection (mL) mean ± SEM (individual % inhibition) Edema % inhibition
1 h 2 h 3 h 4 h
Control 0.463 ± 0.037 0.731 ± 0.085 0.819 ± 0.062 0.642 ± 0.049 -
Indomethacin 10 0.080 ± 0.011** (82.7) 0.144 ± 0.018** (80.3) 0.232 ± 0.052** (71.7) 0.150 ± 0.059** (76.6) 77.2
Phenophase 1 0.232 ± 0.063* (49.9) 0.355 ± 0.035* (51.4) 0.552 ± 0.038* (32.6) 0.399 ± 0.036* (37.9) 42.0
Phenophase 2 0.241 ± 0.039* (47.9) 0.469 ± 0.040* (35.8) 0.547 ± 0.024* (33.2) 0.442 ± 0.031* (31.2) 36.7
Phenophase 3 0.412 ± 0.035 (11.0) 0.532 ± 0.050 (27.2) 0.621 ± 0.066 (24.2) 0.527 ± 0.047 (17.9) 21.1
Phenophase 4 0.257 ± 0.064 (44.5) 0.414 ± 0.074* (43.5) 0.355 ± 0.061* (56.7) 0.469 ± 0.066 (26.9) 36.9
Statistical significance: *p < 0.05, **p < 0.01 Vs control
Table 4: Effect of Peperomia pellucida aqueous extract (EA) p.o. on rat paw edema induced by carragenaan on different plant phases, 
during spring.
Treatment Rat paw volumes after 1, 2, 3, and 4 h after Carrageenan injection (mL) mean ± SEM (individual % inhibition) Edema % inhibition
1 h 2 h 3 h 4 h
Control 0.463 ± 0.037 0.731 ± 0.085 0.819 ± 0.062 0.642 ± 0.049 -
Indomethacin 10 0.080 ± 0.011** (82.7) 0.144 ± 0.018** (80.3) 0.232 ± 0.052** (71.7) 0.150 ± 0.059** (76.6) 77.2
Phenophase 1 0.239 ± 0.042** (48.4) 0.421 ± 0.041** (42.4) 0.450 ± 0.032** (45.1) 0.401 ± 0.034* (37.5) 43.1
Phenophase 2 0.267 ± 0.033** (42.3) 0.392 ± 0.022** (46.4) 0.524 ± 0.026** (36.0) 0.365 ± 0.041* (43.1) 41.6
Phenophase 3 0.332 ± 0.050 (28.3) 0.557 ± 0.040 (23.8) 0.595 ± 0.033** (27.4) 0.519 ± 0.040 (19.2) 24.5
Phenophase 4 0.412 ± 0.076 (11.0) 0.540 ± 0.032* (26.1) 0.522 ± 0.028** (36.3) 0.451 ± 0.030* (29.8) 27.4
Statistical significance: *p < 0.05, **p < 0.01 Vs controlPage 5 of 8
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the plants exhibit raw seeds, ripe seed, and flower stalks
without seeds, which seeds have been already fallen.
Since the plant's leaves are used on infusions or may be
used in a phytotherapic formulation, the number of
leaves per plant should be taken into account when pro-
ducing large quantities of dry plant material. Spring repre-
sents the most productive season. In order to verify the
viability to produce P. pellucida leaves during other sea-
sons a financial study should be performed.
Anti-inflammatory activity
The P. pellucida aqueous extract inhibited the inflamma-
tion process during all phenophases, although not as
much as indomethacin. As shown on Table 1, during sum-
mer there was no statistically significant edema inhibition
induced by carragenaan at the first hour of experiment for
all phenophases. However during the second, third, and
fourth hours there were moderate edema inhibitions (Ta-
ble 1). The rat paw edema experiment is a classical model
of acute inflammation used in the study of non-steroidal
anti-inflammatory drugs involving various types of chem-
ical mediators of inflammation, such as histamine, serot-
onin, bradykinin, and prostaglandines.[20,21] At the first
hour of inhibition histamine is the major mediator found
in the inflammation process. Experimental data from Ta-
ble 1 suggest the P. pellucida aqueous extract is not in-
volved with the histamine system to act as an
antiedematogenic drug.
Table 2 shows the experiments conducted with plants cul-
tivated and collected during fall. It was not detected statis-
tically significant inhibition during phenophase 1,
suggesting a lower concentration of antiedematogenic
compounds in the plant during this phase. Nonetheless
phenophases 3 and 4 show inhibition of the edema at the
first hour. These results suggest that several compounds
might be involved on the antiedematogenic process. Phe-
nophase 4 showed higher inhibition values.
During winter (Table 3) the P. pellucida aqueous extract
showed significant antiedematogenic activity during phe-
nophases 1 and 2 starting from the first hour of inflamma-
tion. Plants collected during phenophase 3 did not show
significant edema inhibition, however during phen-
ophase 4 the antiedematogenic effect was observed only
at the second and third hours of experiment. The experi-
ments suggest that P. pellucida has different concentrations
of chemical agents responsible for the antiedematogenic
effect. In view of these facts the best periods to collect the
plant to use as an antiedematogenic agent are phen-
ophases 1 and 2 of winter and spring. We may consider as
anti-inflammatory any substance, which inhibits the car-
rageenan effects, such as the aqueous extract of P. pellucida
collected during phenophases with highest values of inhi-
bition.
Conclusions
P. pellucida possesses a phenological cycle of approximate-
ly 100 days. The aqueous extract showed antiedematogen-
ic effect especially during phenophases 1 and 2 of winter
and spring. P. pellucida shows antiedematogenic on some
development phases, other phenophases show little activ-
ity. It is only recommended to use the P. pellucida extract
as anti-inflammatory during phenophases 1 and 2 of win-
ter and spring. More investigation is being conducted to
find out which compounds are responsible for the antie-
dematogenic activity.
Material and methods
Cultivation and phenological studies
Seeds were collected by Dr. Arie Fitzgerald Blank from na-
tive Peperomia pellucida plants in our campus, followed by
their processing and germination tests. The species exsic-
cate was identified by our herbalist (Gilvane V. Souza, Bi-
ology Department) and deposited in our University's
herbarium under voucher number 03229.
Seeds germinative capacity was determined using four
Petri dishes, loading 100 seeds in each dish, and keeping
with distilled water under room temperature. Since north-
east of Brazil is a tropical zone and this species is native in
this region, there was no need to control temperature and
humidity.
In order to perform the phenological assay, seedlings were
produced in polyethylene trays (30 × 40 × 8 cm), kept un-
der a 70% black screen, in our campus, using a mixture of
vegetal earth and bovine manure (1:1) as substrate. Seed-
lings were transplanted to three polyethylene trays (30 ×
40 × 8 cm) when they were about 1 cm high, using the
same substrate above mentioned, adding only six plants
per tray. The assays were performed in the same environ-
ment above mentioned. Data collection was performed
twice a week from December 1999 to November 2000,
comprehending the Brazilian summer of 1999/2000 and
fall, winter, and spring of 2000. The average temperatures
during summer and winter are 30°C and 25°C, respec-
tivelly. The following plant characteristics were evaluated:
plant height, number of leaves per plant, number of total
efflorescence per plant, number of flower stalks with ma-
ture seeds, and number of flower stalks without seeds. On
each season we performed the cultivation and conduction
of the assays as described before.
Pharmacological tests were performed using another set
of P. pellucida plants cultivated under the same conditions
above mentioned. In order to verify the changes on bio-
logical activity during the seasons and phases we per-Page 6 of 8
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vegetative (complete development), beginning of bloom,
complete bloom, and seed set.
Aqueous extract preparation
For each phenophase the plant's leaves were dried at 40°
C in a forced air oven (Marconi MA 037) and triturated us-
ing a mill in order to obtain a powder. Distilled water
(1:10 w/v) at 100° C was added to the triturated powder,
constituting the aqueous extract. The extract was infused
for 30 min, filtered and lyophilized and used on pharma-
cological tests. The yield of the aqueous extract was 9.5%
w/w. In order to perform all experiments the extract was
reconstituted in enough water to make a 100 mg/mL solu-
tion and administered p.o. 60 minutes before the experi-
ment.
Animals
Wistar rats (120-200 g) male and female were used as test
animals. The animals were maintained in plastic boxes,
with food and water ad libitum. The animals submitted to
oral administration of the extract or drugs were fasted for
12 hours.
Drugs preparation
Drugs used in the experiments were diluted in a way to
obtain an injection volume of 0.1 mL/10 g (animal
weight), except when defined in the text. Each drug was
dissolved in appropriate solvents as follows: Indometh-
acin (Sigma), diluted in water/0.1 N NaOH (pH = 8); car-
rageenan 1% (Sigma), in saline solution.
Anti-inflammatory activity
The anti-inflammatory activity was evaluated using the rat
paw edema test induced by carrageenan, using Wistar rats,
according to the methodology of Winter et al.[22] Eight
Wistar rats received, p.o., indomethacin (10 mg/Kg) as
positive control, and other groups of eight rats received
the P. pellucida aqueous extract (400 mg/Kg) for all four
distinct phenophases, 1 h before subplantar injection of
carrageenan (0.1 mL/paw, 1% solution). The aqueous ex-
tract concentration was determined according to a previ-
ous publication.[23] The paw volume was measured at
the time 0, then measured again 1, 2, 3, and 4 h after car-
rageenan administration, by the water displacement
method measured with the help of a plethysmometer
(model 7150, Ugo Basile).
Statistical analysis
The inflammation test results were analyzed by ANOVA
followed by the Tukey test and expressed as an mean ±
standard error mean (SEM). Inhibition percents were cal-
culated by the formula: % edema inhibition = (1 - Vt/Vc)
× 100, where Vt and Vc represent the average paw volume
of the treated and control groups, respectively. Individual
percentages were also computed and are show below rat
paw volumes.
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